Page last updated: 2024-12-06

sitamaquine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID42548
CHEMBL ID57004
SCHEMBL ID1070741
MeSH IDM0406752

Synonyms (35)

Synonym
n',n'-diethyl-n-(6-methoxy-4-methyl-8-quinolyl)hexane-1,6-diamine
wr 6026
n,n-diethyl-n'-(6-methoxy-4-methyl-8-quinolinyl)-1,6-hexanediamine
5330-29-0
nsc2452
wr 6026 dihydrochloride
sitamaquine
wr6026
CHEMBL57004
n',n'-diethyl-n-(6-methoxy-4-methylquinolin-8-yl)hexane-1,6-diamine
57695-04-2
drg-0140
6-methoxy-8-(6-diethylaminohexylamino)-4-methylquinoline
wr 006026
wr-6026
n,n-diethyl-n'-(6-methoxy-4-methyl-8-quinolyl)hexane-1,6-diamine
sitamaquine [inn:ban]
5aij4tgc6b ,
unii-5aij4tgc6b
8-((6-(diethylamino)hexyl)amino)-6-methoxy-4-methylquinoline
1,6-hexanediamine, n,n-diethyl-n'-(6-methoxy-4-methyl-8-quinolinyl)-
sitamaquine [inn]
sitamaquine [who-dd]
sitamaquine [mi]
DB04909
SCHEMBL1070741
sitamaquine,n,n-diethyl-n'-(6-methoxy-4-methyl-quinolin-8-yl)-hexane-1,6-diamine
DTXSID70206395
NCGC00386990-01
mmv000063
BCP07171
Q27095559
2,5-dimethoxy-4-nitrostilbene
sr-05000022548
SR-05000022548-1

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The (-)-enantiomer NPC1161B was found to be more active (by severalfold, depending on the dosing regimen) than the (+)-enantiomer NPC1161A in all of these murine models."( Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.
Ager, AL; Bartlett, MS; Croft, SL; Khan, IA; McChesney, JD; Nanayakkara, NP; Walker, LA; Yardley, V, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID100738Antileishmanial activity against Leishmania donovani infections in hamsters (0.05 mg/kg)1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
AID100739Antileishmanial activity against Leishmania donovani infections in hamsters (0.2 mg/kg)1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
AID756039Cytotoxicity against mouse BMDM after 96 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
Anti-leishmanial evaluation of C2-aryl quinolines: mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis.
AID100746Antileishmanial activity against Leishmania donovani infections in hamsters (208 mg/kg)1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
AID530578Antileishmanial activity against GFP-tagged at COOH terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
AID100742Antileishmanial activity against Leishmania donovani infections in hamsters (at 13 mg/kg).1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
AID1595001Antileishmanial activity against promastigote stage of Leishmania donovani MHOM/ET/67/HU3 assessed as parasite growth inhibition after 3 days by MTT assay2019European journal of medicinal chemistry, May-15, Volume: 170Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
AID226271Glucantime (meglumine antimoniate) index (G index) against Leishmania donovani infections in hamsters.1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
AID553788Antileishmanial activity against Leishmania donovani HU3 infected in mouse2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.
AID83838Antileishmanial activity against Leishmania donovani in hamsters at a concentration of 0.81 mg/kg1980Journal of medicinal chemistry, Sep, Volume: 23, Issue:9
Analogues of 8-[[6-(diethylamino) hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents.
AID226267G index = SD90 for meglumine antimoniate / SD90 for the compound1980Journal of medicinal chemistry, Sep, Volume: 23, Issue:9
Analogues of 8-[[6-(diethylamino) hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents.
AID530576Antileishmanial activity against GFP-tagged at NH2 terminus Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
AID83698Antileishmanial activity against Leishmania donovani in hamsters at a concentration of 0.05 mg/kg1980Journal of medicinal chemistry, Sep, Volume: 23, Issue:9
Analogues of 8-[[6-(diethylamino) hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents.
AID162092Minimal effective concentration inhibiting growth of Pneumocystis carinii was reported.1995Journal of medicinal chemistry, Nov-24, Volume: 38, Issue:24
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
AID756040Antileishmanial activity against promastigotes of Leishmania (V.) braziliensis MHOM/CO/87/UA301 after 96 hrs by MTT assay2013Bioorganic & medicinal chemistry, Jul-15, Volume: 21, Issue:14
Anti-leishmanial evaluation of C2-aryl quinolines: mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis.
AID83837Antileishmanial activity against Leishmania donovani in hamsters at a concentration of 0.20 mg/kg1980Journal of medicinal chemistry, Sep, Volume: 23, Issue:9
Analogues of 8-[[6-(diethylamino) hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents.
AID100748Antileishmanial activity against Leishmania donovani infections in hamsters (at 52 mg/kg).1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
AID683704Antimalarial activity against Plasmodium cynomolgi M infected in rhesus monkey administered as po qd for 7 days2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Targeting the liver stage of malaria parasites: a yet unmet goal.
AID530577Antileishmanial activity against Leishmania infantum promastigotes overexpressing LiABCG6 assessed as cell viability after 72 hrs by MTT assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
AID1194921Antileishmanial activity against intracellular amastigote stage of Leishmania donovani MHOM/IN/00/DEVI infected in human THP1 cells assessed as decrease infected macrophages after 120 hrs by microscopy2015Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
AID100740Antileishmanial activity against Leishmania donovani infections in hamsters (0.81 mg/kg)1983Journal of medicinal chemistry, Feb, Volume: 26, Issue:2
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's1 (8.33)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's2 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.13 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]